UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054834
Receipt number R000062658
Scientific Title Effect of Gastroesophageal Reflux Disease (GERD) in Esophageal Cancer
Date of disclosure of the study information 2024/07/01
Last modified on 2024/07/01 15:09:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Gastroesophageal Reflux Disease (GERD) in Esophageal Cancer

Acronym

Effect of Gastroesophageal Reflux Disease (GERD) in Esophageal Cancer

Scientific Title

Effect of Gastroesophageal Reflux Disease (GERD) in Esophageal Cancer

Scientific Title:Acronym

Effect of Gastroesophageal Reflux Disease (GERD) in Esophageal Cancer

Region

Japan


Condition

Condition

Patients with esophageal cancer and gastroesophageal reflux disease

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the impact of GERD in patients with esophageal cancer by performing a detailed pathophysiological evaluation using non-esophageal cancer patients who have previously undergone esophageal pH and impedance testing and esophageal intra-esophageal pressure testing as controls.

Basic objectives2

Others

Basic objectives -Others

Assessment of Pathophysiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Presence or absence of gastroesophageal reflux disease.
Factors to be considered: Questionnaire (presence or absence of gastroesophageal reflux symptoms), esophageal pH and impedance testing (Acid exposure time [AET], reflux frequency [acid, weak acid, alkaline reflux], post-reflux swallow-induced peristaltic wave [PSPW] index, baseline impedance value [MNBI], proximal extent frequency, DeMeester score, acid clearance time, Bolus clearance time), esophageal manometry (presence of esophageal motility disorders [EMDs], IRP value, DCI value EGJ type, EGJ-CI value)

Key secondary outcomes

Factors affecting esophageal cancer.
Factors to be considered: patient background (age, gender, BMI, drinking history, smoking history, presence of flasher, family history, presence of H. pylori infection), endoscopy (grade classification by Lugol's spray, presence of atrophic gastritis, Hill grade, presence of hiatal hernia), blood test (ALDH2)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The applicant must satisfy all of the following 1) to 3).
1) Patients who have undergone esophageal pH/impedance test, esophageal endopressure test, and endoscopy at the Department of Gastroenterology, Chiba University Hospital.
2) Patients who have been diagnosed with esophageal cancer (adenocarcinoma or squamous cell carcinoma).
3) Patients who have received a full explanation of their participation in this study, and who have given written consent of their own free will based on full understanding.

Key exclusion criteria

1) Those who have expressed their refusal to participate in this research through the information disclosure document
2) Other persons deemed unsuitable by the principal investigator.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Tomoaki
Middle name
Last name Matsumura

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code

2648677

Address

1-8-1 Inohana, Chuo Ward, Chiba City, Chiba Prefecture

TEL

43222717

Email

matsumura@chiba-u.jp


Public contact

Name of contact person

1st name Tomomi
Middle name
Last name Ozaki

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code

2648677

Address

1-8-1 Inohana, Chuo Ward, Chiba City, Chiba Prefecture

TEL

43222717

Homepage URL


Email

ozaki.tomomi@chiba-u.jp


Sponsor or person

Institute

Chiba university

Institute

Department

Personal name



Funding Source

Organization

Nothing

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University Hospital

Address

1-8-1 Inohana, Chuo Ward, Chiba City, Chiba Prefecture

Tel

43222717

Email

ozaki.tomomi@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

千葉大学医学部附属病院(千葉県)


Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 05 Month 29 Day

Date of IRB

2024 Year 06 Month 21 Day

Anticipated trial start date

2024 Year 05 Month 29 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Nothing


Management information

Registered date

2024 Year 07 Month 01 Day

Last modified on

2024 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062658